Search

Abstract Printed organic sensors are of significant importance owing to their simplicity, low cost, easy fabrication and solution processability. However, organic sensors often suffer from the drawback of performance degradation when exposed to ambient environment. In this study, polyvinyl alcohol (PVA) is used as the functional layer of a temperature sensor and is encapsulated by aluminum oxide (Al 2 O 3) deposited through spatial atmospheric atomic layer deposition system (SAALD). The encapsulating layer of Al 2 O 3 was pure, atomically thin and highly reliable. Fabricated organic temperature sensor is based on a conductive and uniform interdigitated pattern deposited on a flexible polyethylene naphthalate substrate through advanced printing technology of reverse offset. Thin film of PVA is used as the temperature sensitive functional layer deposited through electrohydrodynamic atomization followed by Al 2 O 3 encapsulation. The developed sensors were tested in the temperature range of 25 °C to 90 °C with relative humidity reaching up to 75% relative humidity. The obtained results exhibited that Al 2 O 3 encapsulation deposited through SAALD significantly enhanced the linearity, repeatability, endurance (50 cycles), retention (2 months) and lifetime of PVA based temperature sensor as compared with the non-encapsulated sensor hence, protecting the organic device from performance degradation. Highlights • Lifetime of organic temperature sensor has been enhanced through encapsulation. • Electrical, mechanical, chemical, and morphological characterizations are included. • The device is encapsulated with Al 2 O 3 thin film deposited through SAALD system. • Encapsulated sensor displayed better results than non-encapsulated sensor. • The obtained results were highly stable and reproducible. [ABSTRACT FROM AUTHOR]

Functional thin film of strontium titanate/polyvinyl alcohol (SrTiO 3 -PVA) hybrid nanocomposite was sandwiched between silver (Ag) electrodes for the application of resistive random access memory (RRAM). Bottom Ag electrodes were patterned using high resolution reverse offset printing system while the hybrid composite thin film and the top Ag electrode were deposited through electro-hydrodynamic (EHD) atomization and EHD patterning respectively. RRAM behavior of SrTiO 3 memory device has not been reported on a flexible substrate due to its brittle nature therefore, in this study we have successfully evaluated its mechanical robustness by forming its nanocomposite with highly flexible PVA polymer. The fabricated device showed bipolar, rewritable and nonvolatile memory behavior at low operating voltage. The bistable resistive switching behavior had off/on ratio of ~30, retention time of 8.64 × 104 s and electrical endurance of 500 operating cycles. The device illustrated mechanical robustness when subjected to 500 bend cycles and varying bending diameters. Image 100539 • A flexible resistive memory device was fabricated using hybrid composite thin film. • SrTiO 3 +PVA thin film was deposited using EHDA spray deposition technique. • All-printed memory device exhibited improved electrical and mechanical endurance. • It showed bistable, rewritable, nonvolatile memory behavior at low working voltage. • The device showed excellent mechanical robustness when tested for 500 bend cycles. [ABSTRACT FROM AUTHOR]

The aim of the work described here was to determine the feasibility of using a novel biopsy needle detection technique that achieves high sensitivity and specificity in a trade-off of resolution, detectability and depth of imaging. The proposed needle detection method consists of a model-based image analysis, temporal needle projection and needle library matching: (i) Image analysis was formulated under the signal decomposition framework; (ii) temporal projection converted the time-resolved needle dynamics into a single image of the desired needle; and (iii) the enhanced needle structure was spatially refined by matching a long, straight linear object in the needle library. The efficacy was examined with respect to different needle visibility. Our method effectively eliminated confounding effects of the background tissue artifacts more robustly than conventional methods, thus improving needle visibility even with the low contrast between the needle and tissue. The improvement in needle structure further resulted in an improvement in estimation performance for the trajectory angle and tip position. Our three-step needle detection method can reliably detect needle position without the need for external devices, increasing the needle conspicuity and reducing motion sensitivity. [ABSTRACT FROM AUTHOR]

Polyethylene oxide (PEO) is a polymer hydrogel possessing ionic conductivity that varies with different percentage of absorbed water molecules and ions. This property makes it a good candidate to be used in humidity sensors’ active layers. The degree of crystallinity of PEO thin films decrease with increasing humidity that facilitates the ion conduction in the thin films, thus reducing the film impedance. In this research work, the humidity sensing properties of the thin films of semi-crystalline PEO have been investigated and the material is then modified to its amorphous dominant phase by heating the thin films beyond the melting point of the polymer. The slowly cooled resulting thin films had a waxy solid like appearance and showed an excellent response towards quantitative detection of relative humidity in the surrounding environment. The results show a roughly linear impedance versus relative humidity curve in the range of 0% RH to 90% RH with a very high maximum achieved sensitivity of ∼35 kΩ/%RH. The response and recovery times measured for the modified sensors were 2.8 s and 5.7 s respectively. The 30 day trial of stability readings showed a standard deviation of only 1%. The results prove thermally modified amorphous PEO thin films to be strong candidates for high end electronic relative humidity sensors. [ABSTRACT FROM AUTHOR]

Fabry disease (FD) is a rare X-linked lysosomal storage disorder that results from the deficient activity of the lysosomal enzyme α-galactosidase A (α-Gal A) enzyme. Kidney transplantation is an option for treating end-stage renal disease in patients with FD. However, only a few cases of kidney transplantation have been reported involving patients with FD and end-stage renal disease and cardiomyopathy after enzyme replacement therapy. A 53-year-old man who underwent peritoneal dialysis was referred to our department because his brother was diagnosed with FD. The diagnosis of FD was also confirmed in our patient on account of the reduced leukocyte α-Gal A enzyme activity and mutation in the α-galactosidase A gene (p.Arg301Gln). Though our patient had end-stage renal disease, he received enzyme replacement therapy with 1 mg/kg agalsidase-β every 2 weeks (Fabrazyme; Genzyme Co, Mass, USA) owing to markedly diffuse cardiac hypertrophy. Six years later, he underwent successful deceased-donor kidney transplantation. The post-transplantation course was uneventful, 4 months after transplantation. However, though he showed T-cell-mediated rejection on kidney biopsy, lamellar lysosomal inclusions were not present in vascular endothelial cells. After several months, a permanent pacemaker was inserted owing to a complete atrioventricular block; the patient died of sepsis and candidemia 1 year later. Deceased-donor kidney transplantation was successfully performed in an FD patient with sustained enzyme replacement therapy. However, owing to high cardiac morbidity and infection risks even after enzyme replacement therapy, close monitoring of these risks is essential for increasing patient survival after kidney transplantation. [ABSTRACT FROM AUTHOR]

In this work, a polymeric material poly(3,4-ethylenedioxythiophene) polystyrene sulfonate (PEDOT:PSS) and a two dimensional material molybdenum disulfide (MoS 2 ) 2D nanoflakes have been employed as the active layers of two separate transducers on a single substrate for the detection of relative humidity. The portion with MoS 2 based active region showed high responsivity towards low humidity levels while PEDOT:PSS based portion responded well to high humidity levels. These two sensing portions were connected in a series combination to fabricate a single humidity sensing device capable to respond to a wide range of relative humidity with very high sensitivity. 2D MoS 2 nanoflakes were obtained by aqueous exfoliation of pristine MoS 2 . The transducer electrode pairs were fabricated using reverse offset printing technique on a piezoelectric LiNbO 3 substrate. The active thin film of MoS 2 flakes was deposited by Electrohydrodynamic atomization (EHDA) while the thin film of PEDOT:PSS was deposited by SAW-EHDA hybrid system. The fabricated sensor is capable of sensing relative humidity with high sensitivity (50 kΩ/%RH or 800 Hz/%RH) in a wide range of 0%RH–80%RH. The response and recovery times are also excellent with values of 0.5 s and 0.8 s respectively. This unique approach of combining multiple transducers in a single sensing device can lead to the development of high performance sensors and can solve the current limitations of single transducer based sensing devices. [ABSTRACT FROM AUTHOR]

PAI-1 and CTGF are overexpressed in kidney diseases and cause fibrosis of the lungs, liver, and kidneys. We used a rat model of unilateral ureteral obstruction (UUO) to investigate whether 6-BIO, a glycogen synthase kinase-3β inhibitor, attenuated fibrosis by inhibiting PAI-1 and CTGF in vivo. Additionally, TGFβ-induced cellular fibrosis was observed in vitro using the human kidney proximal tubular epithelial cells (HK-2), and rat interstitial fibroblasts (NRK49F). Expression of fibrosis-related proteins and signaling molecules such as PAI-1, CTGF, TGFβ, αSMA, SMAD, and MAPK were determined in HK-2 and NRK49F cells using immunoblotting. To identify the transcription factors that regulate the expression of PAI-1 and CTGF the promoter activities of AP-1 and SP-1 were analyzed using luciferase assays. Confocal microscopy was used to observe the co-localization of AP-1 and SP-1 to PAI-1 and CTGF. Expression of PAI-1, CTGF, TGFβ, and α-SMA increased in UUO model as well as in TGFβ-treated HK-2 and NRK49F cells. Furthermore, UUO and TGFβ treatment induced the activation of P-SMAD2/3, SMAD4, P-ERK 1/2, P-P38, and P-JNK MAPK signaling pathways. PAI-1, CTGF, AP-1 and SP-1 promoter activity increased in response to TGFβ treatment. However, treatment with 6-BIO decreased the expression of proteins and signaling pathways associated with fibrosis in UUO model as well as in TGFβ-treated HK-2 and NRK49F cells. Moreover, 6-BIO treatment attenuated the expression of PAI-1 and CTGF as well as the promoter activities of AP-1 and SP-1, thereby regulating the SMAD and MAPK signaling pathways, and subsequently exerting anti-fibrotic effects on kidney cells. [Display omitted] • 6-BIO inhibits UUO- and TGFβ induced kidney fibrosis. • 6-Bio reduces PAI-1 and CTGF expression associated with kidney fibrosis. • 6-BIO regulates AP-1 and SP-1 transcription activity in kidney cells. [ABSTRACT FROM AUTHOR]

[Display omitted] ACE inhibitors or angiotensin II receptor blockers (ACEi/ARBs) have been a cornerstone of the management in kidney disease, but their use is often limited by undesired systemic effects, such as symptomatic hypotension. To minimize the extra-renal effects of ACEi/ARBs, we formulated hydrophobically modified glycol chitosan (HGC) nanomicelles releasing olmesartan (HGC-Olm) that specifically accumulated in the kidney, and investigated whether kidney-specific delivery of olmesartan by HGC nanomicelles could ameliorate organ damage in Col4a3 −/− mouse, a murine model of progressive chronic kidney disease mimicking human Alport syndrome. Ex vivo tracing demonstrated that intravenously injected HGC-Olm nanomicelles were specifically delivered to the kidney, with sustained release of olmesartan for more than 48 h. Contrary to the conventional delivery of olmesartan via oral route, injection of HGC-Olm nanomicelles did not alter blood pressure in Col4a3 −/− mice. Immunohistochemistry revealed that HGC nanomicelles were diffusely distributed from the cortex and glomeruli to the outer medulla, sparing the inner medulla. Phenotypic analysis showed that the attenuation of kidney fibrosis in the kidney of Col4a3 −/− mice by HGC-Olm nanomicelles was comparable to that noted with conventionally delivered olmesartan. Therefore, our results suggest that HGC-Olm nanomicelles could be a safe and effective alternative drug delivery system for kidney diseases. [ABSTRACT FROM AUTHOR]

• Hydrophobically modified glycol chitosan polymeric nanomicelles (HGC) loaded with hydrophobic drug tacrolimus (TAC). • Selective deposition of TAC into the kidney because of the in-built property of glycol chitosan to target the kidney. • Megalin receptor-mediated endocytosis is involved in the uptake and retention of HGC-TAC nanomicelles in the kidney. • Demonstrates the potential of HGC nanomicelles as a novel strategy to deliver drugs specifically to kidneys without any systemic toxicity. In this study, we propose the use of glycol chitosan for the targeted delivery of hydrophobic drugs such as tacrolimus (TAC) towards the kidney. We synthesized a hydrophobically modified glycol chitosan (HGC) polymeric nanomicelle followed by loading TAC resulting in TAC loaded HGC nanomicelles (HGC-TAC). The HGC-TAC nanomicelles displayed spherical morphology with superior drug loading content and encapsulation efficiency. in vitro and in vivo evaluations demonstrated that HGC-TAC nanomicelles are non toxic and delivered TAC preferentially to kidney while lowering the plasma concentrations. The therapeutic effects of HGC-TAC and unencapsulated ("bare") TAC on the kidneys showed that a single intravenous administration of HGC-TAC achieved a therapeutic efficacy comparable to that obtained from daily intraperitoneal injections of TAC for 14 days without any systemic side effects. Thus, HGC-TAC nanomicelles could be effectively used for delivery of TAC towards the kidney, highlighting its potential as a safe modality for renal-targeted delivery of therapeutics. [ABSTRACT FROM AUTHOR]

Vaspin is a protein present in human serum that can cause type-2 diabetes, obesity, and other cardiovascular diseases. We report fluorescent upconverting nanoparticles (UCNPs)-based lateral flow biosensor for ultrasensitive detection of Vaspin. A pair (primary and secondary) of cognate aptamers was used that has duo binding with Vaspin. UCNPs with a diameter of around 100 nm were used as a tag to label a detection probe (secondary aptamer). A primary aptamer (capture probe) was immobilized on the test zone. Sandwich type hybridization reactions among the conjugate probe, target Vaspin, and primary aptamer were performed on the lateral flow biosensor. In the presence of target Vaspin, UCNPs were captured on the test zone of the biosensor and the fluorescent intensity of the captured UCNPs was measured through a colorimetric app under NIR. Fluorescence intensity indicates the quantity of Vaspin present in the sample. A range of Vaspin concentration across 0.1–55 ng ml−1 with a Limit of detection (LOD) 39 pg ml−1 was tested through this UCNPs based LFSA with high sensitivity, reproducibility and repeatability, whereas it's actual range in human blood is from 0.1 to 7 ng ml−1. Therefore, this research provides a well-suited lateral flow strip with an ultrasensitive and low-cost approach for the early diagnosis of type-2 diabetes and this could be applied to any targets with a duo of aptamers generated. Schematic illustration of the configuration and measurement of the UCNPs based lateral flow aptasensor for VASPIN detection. Image 1 • A fluorescence based aptasensor was developed for quantitative detection of Vaspin. • Upconversion nanoparticles were utilized as highly sensitive signal label. • A covalent conjugate of secondary aptamer was developed as signaling probe, and detected in the nM range. • The sensor design is lateral flow based and can be applied for other targets if duo aptamers are available. [ABSTRACT FROM AUTHOR]